We found that compared with non-AD samples, TAAD samples exhibited significant upregulation of METTL3 but downregulation of FTO, indicating that the level of RNA m6A methylation may increase during the pathological process of AD. This evidence concerns the gene METTL3 and Alzheimer disease.